Clinical Trials: SEARCH[STUDY] TILT[STUDY:STUDY-FIRST-POSTED] ( Survival [STUDY:ALL-FIELDS] )
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 … 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 Next Last
#
NCTID/Status
Study
Last Changed
1
NCT01836744
Active, not recruiting
Active, not recruiting
Survival Rate of Dental Implants Placed in Sinus Lift Performed With Two Different Grafts
Conditions: Dental Implant Survival Rate
Intervention: Survival Rate Dental Implant (OsseoSpeed™)
Conditions: Dental Implant Survival Rate
Intervention: Survival Rate Dental Implant (OsseoSpeed™)
July 1, 2019
2
NCT03157310
Completed
Completed
Bone Metastasis on the Survival of Gefitinib Effective Patients
Conditions: Overal Survival, Non-small Cell Lung Cancer
Intervention: Gefitinib
Conditions: Overal Survival, Non-small Cell Lung Cancer
Intervention: Gefitinib
May 16, 2017
3
NCT02718235
Not yet recruiting
Not yet recruiting
Prospective, Multicenter HCCIS Evaluation Study
Conditions: Hepatocellular Carcinoma
Intervention: Overall Survival
Conditions: Hepatocellular Carcinoma
Intervention: Overall Survival
March 23, 2016
4
NCT02012348
Completed
Completed
Analysis of the Effect of Antimicrobial Soap on Bacterial Survival
Conditions: Survival of Bacteria on Skin After Using Different Soaps
Intervention: Antibacterial Soap With Triclocarban, Antibacterial Soap + Benzalkonium Chloride, Control Soap
Conditions: Survival of Bacteria on Skin After Using Different Soaps
Intervention: Antibacterial Soap With Triclocarban, Antibacterial Soap + Benzalkonium Chloride, Control Soap
March 30, 2016
5
NCT03710616
Recruiting
Recruiting
A Real-world Study to Explore Recurrence/Metastases of the NSCLC Patients and the Impact Factors of Patient Survivals
Conditions: Non-small Cell Lung Cancer
Intervention: Surgeries
Conditions: Non-small Cell Lung Cancer
Intervention: Surgeries
July 31, 2019
6
NCT03291275
Recruiting
Recruiting
Survival Outcomes of Uterine Malignancies in Chinese Population
Conditions: Endometrial Neoplasms; Survival
Intervention: Follow-up For Death And Recurrence
Conditions: Endometrial Neoplasms; Survival
Intervention: Follow-up For Death And Recurrence
February 7, 2018
7
NCT01627366
Completed
Completed
Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors
Conditions: Breast Cancer
Intervention: Survivorship Care Plan
Conditions: Breast Cancer
Intervention: Survivorship Care Plan
July 29, 2016
8
NCT03023228
Completed
Completed
Diabetes To Go: An Inpatient Diabetes Survival Skills Education Program
Conditions: Diabetes Mellitus; Hyperglycemia
Intervention: Diabetes Self-management Education
Conditions: Diabetes Mellitus; Hyperglycemia
Intervention: Diabetes Self-management Education
January 13, 2017
9
NCT03571113
Completed
Completed
Cardiac Arrest Survival Score (CRASS)
Conditions: Cardiac Arrest
Intervention: Survival / Not Survival
Conditions: Cardiac Arrest
Intervention: Survival / Not Survival
June 16, 2018
10
NCT03969550
Completed
Completed
Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?
Conditions: AIDS; Progressive Multifocal Leucoencephalopathy (PML)
Intervention: Measure Of Overall Survival
Conditions: AIDS; Progressive Multifocal Leucoencephalopathy (PML)
Intervention: Measure Of Overall Survival
May 29, 2019
11
NCT02989974
Recruiting
Recruiting
Kentucky LEADS Collaborative: Lung Cancer Survivorship Care Program
Conditions: Lung Cancer
Intervention: KY LEADS Survivorship Care
Conditions: Lung Cancer
Intervention: KY LEADS Survivorship Care
April 1, 2019
12
NCT01843985
Unknown status
Unknown status
Observational Study of Survival Outcomes of Stage IV Cancer Patients
Conditions: Stage IV Cancer (Solid Tumors Only); Survival
Conditions: Stage IV Cancer (Solid Tumors Only); Survival
April 27, 2013
13
NCT03144167
Not yet recruiting
Not yet recruiting
Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy
Conditions: Glioblastoma; Radiotherapy; Chemotherapy
Intervention: Analysis Of Spectroscopic Biomarkers Of Proliferation For Six-month Survival
Conditions: Glioblastoma; Radiotherapy; Chemotherapy
Intervention: Analysis Of Spectroscopic Biomarkers Of Proliferation For Six-month Survival
July 19, 2017
14
NCT03523364
Completed
Completed
Survival Rate of All Ceramic Restorations Treated With Air-Water-Blasting Protocol
Conditions: Survival, Prosthesis
Intervention: Dental Restorations
Conditions: Survival, Prosthesis
Intervention: Dental Restorations
May 1, 2018
15
NCT03993561
Not yet recruiting
Not yet recruiting
Treatment Summary and Survivorship Care Plans (TSSP)
Conditions: Survivorship; Head and Neck Cancer
Intervention: Treatment Summary And Survivorship Care Plan
Conditions: Survivorship; Head and Neck Cancer
Intervention: Treatment Summary And Survivorship Care Plan
August 12, 2019
16
NCT01952184
Completed
Completed
Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.
Conditions: Survival; Embryo Quality
Intervention: CBSvit HS Device, Cryotop SC Device
Conditions: Survival; Embryo Quality
Intervention: CBSvit HS Device, Cryotop SC Device
December 2, 2015
17
NCT03977389
Completed
Completed
Total Wrist Denervation: Survival Study and Functional Outcomes
Conditions: Wrist Arthritis; Survival
Intervention: Total Wrist Denervation
Conditions: Wrist Arthritis; Survival
Intervention: Total Wrist Denervation
June 5, 2019
18
NCT03291262
Recruiting
Recruiting
Survival Outcomes of Ovarian Malignancies in Chinese Population
Conditions: Ovarian Neoplasms; Survival
Intervention: Follow Up For Death And Recurrence
Conditions: Ovarian Neoplasms; Survival
Intervention: Follow Up For Death And Recurrence
November 9, 2018
19
NCT03363685
Recruiting
Recruiting
Verification of Novel Survival Prediction Algorithm for Patients With NSCLC Spinal Metastasis
Conditions: Spinal Metastases; Non-Small-Cell Lung Cancer Metastatic
Conditions: Spinal Metastases; Non-Small-Cell Lung Cancer Metastatic
November 30, 2017
20
NCT03291236
Recruiting
Recruiting
Survival Outcomes of Uterine Cervical Malignancies in Chinese Population
Conditions: Uterine Cervical Neoplasms; Survival
Intervention: Follow-up For Death And Recurrence Of Patients
Conditions: Uterine Cervical Neoplasms; Survival
Intervention: Follow-up For Death And Recurrence Of Patients
February 7, 2018
21
NCT02111616
Completed
Completed
Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot Study
Conditions: Cancer
Intervention: Survivorship Care Plan (SCP), Coordinated PCP Visit
Conditions: Cancer
Intervention: Survivorship Care Plan (SCP), Coordinated PCP Visit
January 19, 2016
22
NCT00981019
Completed
Completed
Doctors' Understanding of Survival Statistics
Conditions: Screening
Conditions: Screening
July 20, 2011
23
NCT03998332
Completed
Completed
Overall Survival of Large Cell Neuroendocrine Lung Cancer Patients - a Retrospective Study
Conditions: Survival Outcomes of Patients With Pulmonary LCNEC
Conditions: Survival Outcomes of Patients With Pulmonary LCNEC
June 27, 2019
24
NCT03539120
Completed
Completed
Post-amputation Survival Following Rehabilitation Medium and Long-term Follow up Study, a Retrospective Analysis.
Conditions: Amputation
Intervention: Follow Up For Survival
Conditions: Amputation
Intervention: Follow Up For Survival
May 25, 2018
25
NCT02816866
Completed
Completed
Comparing Two Modes of Survivorship Care
Conditions: Survivorship Care
Intervention: Empowered Primary Care Model, Specialty Survivor Clinic
Conditions: Survivorship Care
Intervention: Empowered Primary Care Model, Specialty Survivor Clinic
June 28, 2016
26
NCT03747783
Recruiting
Recruiting
Nomograms to Precisely Predict Conditional Risk of Survival for Patients With Laryngeal Cancer
Conditions: Laryngeal Cancer
Intervention: Radical Operation
Conditions: Laryngeal Cancer
Intervention: Radical Operation
November 23, 2018
27
NCT02405819
Completed
Completed
Patient and Provider Initiated Survivorship Care Planning
Conditions: Cancer
Intervention: 'My Care Plan', 'Survivorship Care Plan Builder'
Conditions: Cancer
Intervention: 'My Care Plan', 'Survivorship Care Plan Builder'
April 20, 2016
28
NCT03800212
Recruiting
Recruiting
Survival and Description of Care for Patients With Degenerate Vaterian Ampulloma
Conditions: Ampullary Adenocarcinoma
Intervention: Treatment For Ampullary Adenocarcinoma
Conditions: Ampullary Adenocarcinoma
Intervention: Treatment For Ampullary Adenocarcinoma
January 8, 2019
29
NCT03900871
Not yet recruiting
Not yet recruiting
Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal Carcinoma
Conditions: Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous Cell Carcinoma
Intervention: Acetylsalicylic Acid
Conditions: Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous Cell Carcinoma
Intervention: Acetylsalicylic Acid
April 1, 2019
30
NCT02966769
Completed
Completed
N2 Lung Cancer Project: Neoadjuvant Treatment Followed Surgery Versus Chemoradiation
Conditions: Non-small-Cell Lung Carcinoma; Surgery; Stage IIIA-N2; Chemoradiation; Survival
Intervention: Overall Survival
Conditions: Non-small-Cell Lung Carcinoma; Surgery; Stage IIIA-N2; Chemoradiation; Survival
Intervention: Overall Survival
February 15, 2018
31
NCT02021500
Completed
Completed
A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.
Conditions: Pancreatic Cancer
Intervention: ABI-007
Conditions: Pancreatic Cancer
Intervention: ABI-007
October 31, 2016
32
NCT04054271
Completed
Completed
Effects of ABO Blood Types on the Survival and Marginal Bone Resorption of Dental Implants
Conditions: Implant Tissue Failure
Conditions: Implant Tissue Failure
August 8, 2019
33
NCT03981107
Recruiting
Recruiting
Compression Only CPR Versus Standard CPR in Out-Of-Hospital Cardiac Arrest - A Randomized Survival Study
Conditions: Out-Of-Hospital Cardiac Arrest; Cardiac Arrest; Cardiopulmonary Resuscitation
Intervention: Chest Compression Only CPR (CO-CPR) Performed By Trained Bystanders After Instructions From Dispatchers, Standard CPR (S-CPR) Performed By Trained Bystanders After Instructions From Dispatchers
Conditions: Out-Of-Hospital Cardiac Arrest; Cardiac Arrest; Cardiopulmonary Resuscitation
Intervention: Chest Compression Only CPR (CO-CPR) Performed By Trained Bystanders After Instructions From Dispatchers, Standard CPR (S-CPR) Performed By Trained Bystanders After Instructions From Dispatchers
June 8, 2019
34
NCT03368651
Recruiting
Recruiting
The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.
Conditions: Hepatocellular Carcinoma
Intervention: TAI
Conditions: Hepatocellular Carcinoma
Intervention: TAI
December 8, 2017
35
NCT03439332
Completed
Completed
Multicentre Validation of How Vascular Biomarkers From Tumor Can Predict the Survival of the Patient With Glioblastoma
Conditions: Glioblastoma
Conditions: Glioblastoma
May 21, 2019
36
NCT02129335
Terminated
Terminated
Stress, Exercise Behavior and Survival in Patients With Newly Diagnosed Glioblastoma and in a Close Partner
Conditions: Neoplasms; Glioblastoma
Intervention: Stress
Conditions: Neoplasms; Glioblastoma
Intervention: Stress
May 16, 2017
37
NCT03172988
Terminated
Terminated
Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery
Conditions: Carcinoma, Non-Small-Cell Lung; Surgery; Dexamethasone; Flubiprofen Axetil; Long-term Effects Secondary to Cancer Therapy in Adults
Intervention: Dexamethasone, Normal Saline, Flurbiprofen Axetil, Lipid Microsphere
Conditions: Carcinoma, Non-Small-Cell Lung; Surgery; Dexamethasone; Flubiprofen Axetil; Long-term Effects Secondary to Cancer Therapy in Adults
Intervention: Dexamethasone, Normal Saline, Flurbiprofen Axetil, Lipid Microsphere
March 3, 2019
38
NCT02367261
Completed
Completed
A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of SPI Implant
Conditions: Implant Clinical Survival; Dental Implant Bone Loss
Intervention: SPI Implant
Conditions: Implant Clinical Survival; Dental Implant Bone Loss
Intervention: SPI Implant
June 27, 2017
39
NCT00837993
Completed
Completed
Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System
Conditions: Ovarian Cancer
Conditions: Ovarian Cancer
December 20, 2012
40
NCT01058902
Withdrawn
Withdrawn
The Effect Of Aspirin On Survival in Lung Cancer
Conditions: Non Small Cell Lung Cancer; Survival; Aspirin
Intervention: Aspirin 75 Mg, No Aspirin
Conditions: Non Small Cell Lung Cancer; Survival; Aspirin
Intervention: Aspirin 75 Mg, No Aspirin
March 4, 2016
41
NCT03843398
Not yet recruiting
Not yet recruiting
Survival Outcome After Minilaparotomy for the Treatment of Colorectal Cancer
Conditions: Colorectal Cancer
Intervention: Colorectal Cancer Resection Via Minilaparotomy, Laparoscopic Colorectal Cancer Resection
Conditions: Colorectal Cancer
Intervention: Colorectal Cancer Resection Via Minilaparotomy, Laparoscopic Colorectal Cancer Resection
February 14, 2019
42
NCT01960361
Completed
Completed
A Multi-center Study to Evaluate Bone Loss, Survival Rate and Stability of ICE Implant
Conditions: Implant Clinical Survival; Dental Implant Bone Loss
Intervention: ICE Dental Implant
Conditions: Implant Clinical Survival; Dental Implant Bone Loss
Intervention: ICE Dental Implant
July 14, 2019
43
NCT02934867
Unknown status
Unknown status
Out of Hospital Cardiac Arrest: Trial Assessing the Survival Impact of Phone Advice
Conditions: Out of Hospital Cardiac Arrest
Intervention: Protocol Phone Advice, Usual Phone Advice
Conditions: Out of Hospital Cardiac Arrest
Intervention: Protocol Phone Advice, Usual Phone Advice
October 13, 2016
44
NCT02503007
Completed
Completed
Effects of 14-days of HMB-free Acid on Changes in Muscle During 4-days of Survival Training
Conditions: Survival Training
Intervention: Placebo, HMB-FA
Conditions: Survival Training
Intervention: Placebo, HMB-FA
November 24, 2015
45
NCT03978481
Recruiting
Recruiting
Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study
Conditions: Gastric Cancer
Intervention: Helicobacter Pylori Eradication (combination Therapy)
Conditions: Gastric Cancer
Intervention: Helicobacter Pylori Eradication (combination Therapy)
June 6, 2019
46
NCT02852993
Completed
Completed
Survival After Blood Transfusion in the French Administrative Regions of Burgundy and Franche-Comté
Conditions: Erythrocyte Transfusion for All Conditions
Conditions: Erythrocyte Transfusion for All Conditions
August 1, 2016
47
NCT03384407
Recruiting
Recruiting
Recovery and Lifespan of Red Blood Cells From Pathogen-reduced, Stored Blood Units
Conditions: Red Cell Survival in Healthy Volunteers
Intervention: Red Cell Survival In INTERCEPT Treated Red Cells
Conditions: Red Cell Survival in Healthy Volunteers
Intervention: Red Cell Survival In INTERCEPT Treated Red Cells
January 7, 2019
48
NCT03410758
Completed
Completed
Predictive Factors of Survival With and Without Repetition With 5 and 10 Years Curative Post-oesophagectomy for Cancer of the Oesophagus
Conditions: Esophageal Cancer; Esophageal Surgery Cancer; Overall Survival
Conditions: Esophageal Cancer; Esophageal Surgery Cancer; Overall Survival
February 6, 2018
49
NCT03597425
Recruiting
Recruiting
Prognostic Indicators of Survival Following Cardiopulmonary Resuscitation in Patients With Cardiac Arrest
Conditions: Cardiopulmonary Resuscitation
Intervention: Cardiopulmonary Resuscitation
Conditions: Cardiopulmonary Resuscitation
Intervention: Cardiopulmonary Resuscitation
July 20, 2018
50
NCT04028232
Recruiting
Recruiting
Influence of Socio-Economic Factor on Net Survival in Patients With Multiple Sclerosis in France ( ECOVIMUS).
Conditions: C10.114.375.500
Conditions: C10.114.375.500
July 19, 2019
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 … 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.